Business · 24/04/2017Updated: 10/17/2026 · 1 min read
Guerbet Group Sees FDA Withdraw Approval of Two New Drug Applications
Summary
The FDA is withdrawing approval of two new drug applications submitted by Guerbet Group, following the company's notification that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →